A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease
Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: Results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group